The following bids, mergers, acquisitions and disposals were reported by 1430 GMT on Monday:** Shire Plc has agreed to purchase U.S. group NPS Pharmaceuticals Inc for $5.2 billion, the Dublin-based drugmaker's biggest acquisition yet as it seeks to strengthen its position in the lucrative field of medicines for rare diseases.
NPS Pharmaceuticals, Inc. (NPS) is a biopharmaceutical company focused on pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide. Shares of NPSP traded higher by 8.23% or $3.45/share to $45.36. In the past year, the shares have traded as low as $22.11 and as high as $42.95. On average, 1585980 shares of NPSP exchange hands on a given day and today's volume is recorded at 34414800.
Shire plc (Shire) is a specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shares of SHPG fell by 1.69% or $-3.67/share to $213.82. In the past year, the shares have traded as low as $141.32 and as high as $264.98. On average, 1904920 shares of SHPG exchange hands on a given day and today's volume is recorded at 256654.
Source
